Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

IFN-gamma activates the C3G/Rap1 signaling pathway.

Y Alsayed1, S Uddin, S Ahmad

  • 1Section of Hematology-Oncology, University of Illinois at Chicago 60607, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|February 5, 2000
PubMed
Summary

Interferon-gamma (IFN-gamma) activates a novel signaling pathway involving c-cbl, CrkL, and Rap1, contributing to its growth inhibitory effects. This pathway differs from the Stat pathway and is also activated by Type I IFNs.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Knight Scholars Program: A Tiered Three-Year Mentored Training Program for Urban and Rural High School High School Students Increases Interest and Self-Efficacy in Interprofessional Cancer Research.

Journal of STEM outreach·2023
Same author

Diversity of coronary arterial tree in laboratory mice.

Folia morphologica·2019
Same author

Human SLFN5 is a transcriptional co-repressor of STAT1-mediated interferon responses and promotes the malignant phenotype in glioblastoma.

Oncogene·2017
Same author

Recurrent cyclin D2 mutations in myeloid neoplasms.

Leukemia·2017
Same author

Relapse of Hodgkin's Disease After 14 Years of Complete Remission.

Leukemia & lymphoma·2016
Same author

Discovery and functional characterization of a germline, CSF2RB-activating mutation in leukemia.

Leukemia·2016

Area of Science:

  • Immunology
  • Cell Signaling
  • Oncology

Background:

  • Interferon-gamma (IFN-gamma) is a key cytokine involved in immune responses and cell growth regulation.
  • IFN-gamma signaling typically involves Janus kinases (Jak-1, Jak-2) and the Stat-1 transcription factor.
  • The complete signaling network of IFN-gamma, particularly its growth inhibitory mechanisms, remains incompletely understood.

Purpose of the Study:

  • To elucidate novel signaling cascades activated by IFN-gamma.
  • To investigate the role of c-cbl, CrkL, and Rap1 in IFN-gamma signal transduction.
  • To compare IFN-gamma signaling with Type I interferons (IFN-alpha, IFN-beta).

Main Methods:

  • Treatment of NB-4 human cells with IFN-gamma.
  • Analysis of protein tyrosine phosphorylation using immunoprecipitation.

Related Experiment Videos

  • Assessment of protein-protein interactions via co-immunoprecipitation.
  • Monitoring of guanine nucleotide exchange factor activity and small GTPase activation.

    • Main Results:

    • IFN-gamma induces rapid tyrosine phosphorylation of c-cbl, creating a docking site for CrkL.
    • CrkL interacts with c-cbl and regulates the activation of guanine exchange factor C3G.
    • This cascade leads to the activation of the small G protein Rap1, known for tumor suppressor activity.
    • Rap1 activation by IFN-gamma is distinct from Stat-1 activation and shares similarities with Type I IFN signaling pathways.
    • Differential regulation of CrkL downstream pathways by IFN-gamma versus Type I IFNs was observed.

    Conclusions:

    • IFN-gamma activates a novel signaling pathway involving c-cbl, CrkL, and Rap1, independent of the Stat pathway.
    • This newly identified cascade likely contributes significantly to the growth inhibitory effects of IFN-gamma.
    • Understanding these distinct pathways provides insights into differential interferon functions and therapeutic potential.